Literature DB >> 22252428

GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area.

Stefanie Reyes1, Yuhong Fu, Kay Double, Lachlan Thompson, Deniz Kirik, George Paxinos, Glenda M Halliday.   

Abstract

G-protein-regulated inward-rectifier potassium channel 2 (GIRK2) is reported to be expressed only within certain dopamine neurons of the substantia nigra (SN), although very limited data are available in humans. We examined the localization of GIRK2 in the SN and adjacent ventral tegmental area (VTA) of humans and mice by using either neuromelanin pigment or immunolabeling with tyrosine hydroxylase (TH) or calbindin. GIRK2 immunoreactivity was found in nearly every human pigmented neuron or mouse TH-immunoreactive neuron in both the SN and VTA, although considerable variability in the intensity of GIRK2 staining was observed. The relative intensity of GIRK2 immunoreactivity in TH-immunoreactive neurons was determined; in both species nearly all SN TH-immunoreactive neurons had strong GIRK2 immunoreactivity compared with only 50-60% of VTA neurons. Most paranigral VTA neurons also contained calbindin immunoreactivity, and approximately 25% of these and nearby VTA neurons also had strong GIRK2 immunoreactivity. These data show that high amounts of GIRK2 protein are found in most SN neurons as well as in a proportion of nearby VTA neurons. The single previous human study may have been compromised by the fixation method used and the postmortem delay of their controls, whereas other studies suggesting that GIRK2 is located only in limited neuronal groups within the SN have erroneously included VTA regions as part of the SN. In particular, the dorsal layer of dopamine neurons directly underneath the red nucleus is considered a VTA region in humans but is commonly considered the dorsal tier of the SN in laboratory species.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252428     DOI: 10.1002/cne.23051

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  40 in total

Review 1.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

Review 2.  The neuroanatomic complexity of the CRF and DA systems and their interface: What we still don't know.

Authors:  E A Kelly; J L Fudge
Journal:  Neurosci Biobehav Rev       Date:  2018-04-25       Impact factor: 8.989

3.  Cellular GABAergic Neuroactive Steroid (3α,5α)-3-Hydroxy-Pregnan-20-One (3α,5α-THP) Immunostaining Levels Are Increased in the Ventral Tegmental Area of Human Alcohol Use Disorder Patients: A Postmortem Study.

Authors:  Ahmet Sait Hasirci; Antoniette M Maldonado-Devincci; Matthew C Beattie; Todd K O'Buckley; A Leslie Morrow
Journal:  Alcohol Clin Exp Res       Date:  2017-01-09       Impact factor: 3.455

Review 4.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

5.  Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.

Authors:  Konrad M Ricke; Thomas Paß; Sammy Kimoloi; Kai Fährmann; Christian Jüngst; Astrid Schauss; Olivier R Baris; Marijana Aradjanski; Aleksandra Trifunovic; Therese M Eriksson Faelker; Matteo Bergami; Rudolf J Wiesner
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

Review 6.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

7.  Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.

Authors:  Isabelle R de Luzy; Jonathan C Niclis; Carlos W Gantner; Jessica A Kauhausen; Cameron P J Hunt; Charlotte Ermine; Colin W Pouton; Lachlan H Thompson; Clare L Parish
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

8.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease.

Authors:  Stephanie L Alberico; Martin D Cassell; Nandakumar S Narayanan
Journal:  Basal Ganglia       Date:  2015-08-01

Review 9.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

10.  iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.

Authors:  A H Laperle; S Sances; N Yucer; V J Dardov; V J Garcia; R Ho; A N Fulton; M R Jones; K M Roxas; P Avalos; D West; M G Banuelos; Z Shu; R Murali; N T Maidment; J E Van Eyk; M Tagliati; C N Svendsen
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.